Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158498 | 0.76 | — | — | |
| SCHEMBL9020969 | 0.76 | — | — | |
| SCHEMBL5897167 | 0.75 | BRD4 (0.44) | BRD4BRD2GAASMN1; SMN2 | |
| SCHEMBL2238464 | 0.75 | — | — | |
| SCHEMBL2244443 | 0.75 | KDM4E (0.32) | GAAPOLBTDP1 | |
| SCHEMBL17433536 | 0.73 | BRD4 (0.68) | BRD4BRD2GAASMN1; SMN2LMNA | |
| SCHEMBL11930013 | 0.73 | BRD4 (0.38) | BRD4BRD2GAASMN1; SMN2 | |
| SCHEMBL11588851 | 0.71 | POLB (0.38) | BRD4BRD2SMN1; SMN2POLBTDP1 | |
| SCHEMBL2239140 | 0.69 | KMT2A (0.32) | BRD4BRD2 | |
| SCHEMBL13684324 | 0.68 | SMN1; SMN2 (0.41) | BRD4BRD2GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7994330-B2 | Oxidizing p-xylene to terephthalic acid using a catalyst having a dicarboximide skeleton; hydrothermally treating the product with hot water, decomposing and removing catalyst impurities | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7524986-B2 | Methods for producing aromatic carboxylic acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20080171881-A1 | Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-07-17 | — | — | US | disclosed |
| EP-1870394-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND METHOD FOR DECOMPOSING COMPOUND HAVING DICARBOXYIMIDE SKELETON | Daicel Chemical Industries, Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
| US-7288649-B2 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-10-30 | — | — | US | disclosed |
| US-20070191634-A1 | Methods for producing aromatic carboxylic acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1734029-A1 | PROCESS FOR PRODUCING AROMATIC CARBOXYLIC ACID | Daicel Chemical Industries, Ltd. (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1342715-B1 | Process for producing oximes using nitirites | DAICEL CHEM (JP) | 2006-09-13 | — | — | EP | disclosed |
| US-7091342-B2 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-15 | — | — | US | disclosed |
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | ISHII YASUTAKA | 2006-02-09 | — | — | US | disclosed |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| EP-1459804-A1 | CATALYSTS COMPRISING CYCLIC ACYLUREA COMPOUNDS AND PROCESSES FOR PRODUCTION OF ORGANIC COMPOUNDS WITH THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6768023-B2 | REACTING AN ESTER OR SALT OF NITROUS ACID WITH A COMPOUND THAT GENERATES A FREE RADICAL IN THE PRESENCE OF A NITROGEN CONTAINING CYCLIC COMPOUND CONTAINING AN N-OXY OR -HYDROXY IMIDE GROUP; FORMING OXIMES, NITRO COMPOUNDS, AND KETONES | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20030171618-A1 | Process for producing organic compounds using nitrites | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1342715-A2 | Process for producing oximes using nitirites | Daicel Chemical Industries, Ltd. (JP) | 2003-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171618-A1 | Process for producing organic compounds using nitrites | NOS1, NOS2, NOS3 | BRD4 4162/4885BRD2 3812/4885GAA 3745/4885 |
| US-20080171881-A1 | Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton | DHPS, OGDH, MCCC2 | BRD4 1988/4885BRD2 2416/4885GAA 2142/4885 |
| US-20070191634-A1 | Methods for producing aromatic carboxylic acids | PAH, AHR, HAO2 | BRD4 3269/4885BRD2 3617/4885GAA 793/4885 |
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | MOGAT2, HAT1, ACOX1 | BRD4 3479/4885BRD2 3278/4885GAA 384/4885 |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | MOGAT2, ACSS2, ACOX1 | BRD4 3616/4885BRD2 3379/4885GAA 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.